Ryman’s turnaround is well under way: Forsyth Barr

Ryman’s turnaround is well under way: Forsyth Barr
Forsyth Barr's Aaron Ibbotson rates Ryman shares as "outperform". (Image: Forsyth Barr)
Jenny Ruth
Forsyth Barr analyst Aaron Ibbotson has taken a deep dive into Ryman Healthcare‘s debt position and its turnaround strategy and concluded it is “changing its stripes more than the market is giving it credit for”.The market has certainly exhibited extreme disillusion with the stock in recent weeks.Ryman shares fell as low as $4.82 after it completed its $902 million capital raising, compared with the rights issue price of $5 per new share and $6.40 before the mid-February announcement.The shares closed at $5.22 on Tuesday.A goo...

More Markets

Goodman Property expects more of the same
Property

Goodman Property expects more of the same

Stable property values helped the company report net profit after tax of $109.6m.

Australia standout in Mainfreight’s 'satisfactory' result
Infrastructure

Australia standout in Mainfreight’s 'satisfactory' result

New government depreciation rules won’t change its investment plans.

Trade Window sees ebitda breakeven for FY26
Markets

Trade Window sees ebitda breakeven for FY26

The company has shaved costs, grown revenue and benefited from trade turmoil.

Green Cross Health navigates tough year with $16m profit
Markets

Green Cross Health navigates tough year with $16m profit

The company is navigating a 'challenging healthcare landscape'.